Page last updated: 2024-11-05

triazolam and Apnea

triazolam has been researched along with Apnea in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Apnea: A transient absence of spontaneous respiration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Rocha, A1
Pinto, ACPN1
Pachito, DV1
Drager, LF1
Lorenzi-Filho, G1
Atallah, ÁN1
Attallah, A1
Seilanian, M1
Bavoux, F1
Choisy, H1

Reviews

1 review available for triazolam and Apnea

ArticleYear
Pharmacological treatment for central sleep apnoea in adults.
    The Cochrane database of systematic reviews, 2023, 02-27, Volume: 2

    Topics: Acetazolamide; Adult; Aged; Apnea; Buspirone; Carbonic Anhydrase Inhibitors; Disorders of Excessive

2023

Other Studies

1 other study available for triazolam and Apnea

ArticleYear
[Psychotropics and pregnancy. Apropos of 2 case reports: the dose of triazolam].
    Revue francaise de gynecologie et d'obstetrique, 1989, Volume: 84, Issue:1

    Topics: Apnea; Female; Half-Life; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pr

1989